HOME >> BIOLOGY >> NEWS
Study calls for cheaper antitoxins for plant poisoning in less-developed countries

Antitoxins for plant poisoning and antidotes to snake venom should be included in the global drive to reduce costs and increase access to drugs in less-developed regions of the world, conclude authors of a research letter in this week's issue of THE LANCET.

Oleander self-poisoning is common in Sri Lanka-especially among young women-and an effective antitoxin was withdrawn after one year of use due to its high cost-around $2650 per treatment.

Michael Eddleston from the University of Colombo, Sri Lanka, and colleagues investigated the effect of the antitoxin's introduction and withdrawal on case fatality, and determined its cost-effectiveness. They report how the antitoxin strikingly reduced the case fatality; its absence resulted in a three-fold rise in deaths. At the present price of US$2650 per course, every life saved cost around $10,000, and every life year cost around $250. Reduction of the antitoxin's price to $400 would reduce costs to $1137 per life gained; a further reduction to $103 would save money for every life gained. Michael Eddleston comments: "There is presently a worldwide effort to develop and make available affordable drugs for tropical diseases; however, this effort seems to be passing by poisoning and envenoming. Treatments for poisoning and envenoming should be included in the campaign to increase the availability of affordable treatments. Both are significant problems in poor rural areas of the tropics, yet there is a dearth of affordable antivenoms for snake bites and antitoxins for plant poisoning. Although digoxin-specific antibodies were not patented on ethical grounds when developed in 1975, they are now unavailable in Sri Lanka because of their cost."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
25-Sep-2003


Page: 1

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... , ... May 22, 2017 , ... ... with other leaders of the Maryland Biohealth community in developing and issuing recommendations ... Top 3 U.S. BioHealth Innovation Hub by 2023. , The ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... ... that helps avoid the lengthy trial and error process by finding the right ... It can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... April 28, 2017 at the Prince Of Wales Private Hospital. The procedure was ... level C6-C7. The patient failed conservative treatments prior to undergoing surgery. , The ...
(Date:5/18/2017)... ... 17, 2017 , ... NDA Partners Chairman Carl Peck, MD , announced ... Laboratories and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined the ... Health, he was former Chief Operating Officer at Anaborex, Senior VP and General Manager ...
Breaking Biology Technology:
Cached News: